Ovarian cancer patients denied innovative drug amid cost concerns

The GuardianOvarian cancer patients denied innovative drug amid cost concernsThe GuardianHowever, cancer charities were dismayed, pointing out that the death toll in ovarian cancer was very high and that the drug was available elsewhere in Europe. Cancer Research UK said the decision was “hard to understand”. The Institute of Cancer ...Ovarian cancer drug row: 'Breakthrough' treatment won't be available on the ...Daily MailNICE says AZ' ovarian cancer drug is too expensivePharmaTimesall 19 news articles »

Share this post